Overall survival and PD-L1 expression in metastasized malignant melanoma.

Abstract

Correlation of overall survival with PD-L1 expression by melanoma cells remains controversial, and future clinical studies should focus on antibody validation and time of analysis in respect to disease progression.

Full Text

• DOI - Cancer (DOI)
• John Wiley & Sons, Inc. - full-text online
• Swets Information Services - full-text online
• OhioLINK Electronic Journal Center - full-text online
• EBSCO - full-text online

Subjects

• Adolescent
• Adult
• Aged
• Aged, 80 and over
• Antigens, CD
• Disease Progression
• Female
• Humans
• Lymphocytes, Tumor-Infiltrating
• Male
• Melanoma
• Middle Aged
• Neoplasm Metastasis
• Paraffin Embedding
• Prognosis
• Skin Neoplasms
• Staining and Labeling
• Tumor Markers, Biological

Similar articles

• PD-1 expression on Melan-A-reactive T cells increases during progression to metastatic disease. (2012-03-16)
• Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma. (2010-03-29)
• The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibition. (2012-10-24)
• Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: a 5-year-follow-up study. (2013-02-07)
• PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction. (2013-01-22)
• Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma. (2013-04-24)
• Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma. (2013-03-27)
• Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types. (2013-03-05)
• Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. (2009-06-09)

Authors

• Jules Gadiot
• Anna I Hooijkaas
• Andrew D M Kaiser
• Harm van Tinteren
• Hester van Boven
• Christian Blank

Publication date

2011-04-27

Journal

Journal topics

• Neoplasms

Language

Eng.

Copyright

Cancer

Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Amsterdam, The Netherlands.

Release reference

Cancer. 2011 May;117(10):2192-201

Related books

• Books of Antigens, CD
• Books of Disease Progression
• Books of Lymphocytes, Tumor-Infiltrating
• Books of Melanoma
• Books of Neoplasm Metastasis
• Books of Neoplasms
• Books of Paraffin Embedding
• Books of Prognosis
• Books of Skin Neoplasms
• Books of Staining and Labeling
• Books of Tumor Markers, Biological